
  
    
      
        Background_NNP
        The_DT human_JJ disorder_NN of_IN sitosterolemia_NN ,_, also_RB known_VBN as_IN
        phytosterolemia_NN (_( MIM_NNP 210250_CD )_) ,_, is_VBZ an_DT autosomal_NN recessive_JJ
        disorder_NN characterized_VBN by_IN the_DT marked_VBN elevation_NN of_IN plasma_NN
        phytosterols_NNS e_SYM ._. g_SYM ._. β-sitosterol_JJ ,_, campesterol_NN and_CC
        stigmasterol_NN [_NN 1_CD 2_CD ]_NN ._. Hypercholesterolemia_NNP primarily_RB
        during_IN childhood_NN ,_, accelerated_VBD atherosclerosis_NNS in_IN some_DT adult_NN
        patients_NNS leading_VBG to_TO premature_JJ death_NN ,_, as_IN well_RB a_DT hemolytic_JJ
        anaemia_NN ,_, arthralgias_NNS and_CC tendon_NN and_CC tuberous_JJ xanthoma_NN
        formations_NNS are_VBP other_JJ clinical_JJ features_NNS ._. Studies_NNS have_VBP shown_VBN
        that_IN the_DT sitosterolemic_JJ patients_NNS hyperabsorb_NN all_DT sterols_NNS
        (_( cholesterol_NN and_CC phytosterols_NNS )_) and_CC fail_VB to_TO excrete_NN
        phytosterols_NNS into_IN bile_NN [_NN 3_CD 4_CD 5_CD 6_CD 7_CD ]_NN ._. Positional_NNP mapping_NN
        of_IN the_DT 
        STSL_NNP locus_JJ to_TO human_JJ chromosome_NN 2_CD p_NN 21_CD
        led_VBN to_TO the_DT identification_NN of_IN two_CD genes_NNS ,_, ATP_NNP binding_JJ
        cassette_NN (_( ABC_NNP )_) half-transporters_JJ G_NNP 5_CD and_CC G_NNP 8_CD that_WDT were_VBD
        mutated_VBN in_IN affected_VBN individuals_NNS [_NN 8_CD 9_CD 10_CD 11_CD 12_CD ]_NN ._. The_DT
        protein_NN products_NNS of_IN these_DT two_CD genes_NNS (_( sterolin-_NN 1_CD and_CC
        sterolin-_NN 2_CD respectively_RB )_) are_VBP thought_VBN to_TO form_VB heterodimers_NNS
        to_TO constitute_VB a_DT functional_JJ transporter_NN ,_, based_VBD primarily_RB on_IN
        the_DT genetic_JJ evidence_NN that_WDT affected_VBD individuals_NNS are_VBP either_CC
        completely_RB mutated_VBN in_IN sterolin-_NN 1_CD or_CC sterolin-_NN 2_CD ,_, but_CC not_RB
        both_DT [_NN 12_CD ]_NN ._. More_RBR recently_RB ,_, evidence_NN from_IN in_IN vitro_NN
        expression_NN of_IN these_DT proteins_NNS has_VBZ been_VBN presented_VBN that_IN these_DT
        two_CD proteins_NNS co-immunoprecipitate_JJ ,_, supporting_VBG this_DT
        conclusion_NN [_NN 13_CD ]_NN ._. ABCG_NNP 5_CD and_CC ABCG_NNP 8_CD appear_VB to_TO be_VB present_JJ in_IN
        all_DT mammalian_JJ genomes_NNS examined_VBD to_TO date_NN and_CC are_VBP highly_RB
        conserved_JJ between_IN species_NNS ,_, indicating_VBG that_IN these_DT genes_NNS may_MD
        have_VB a_DT similar_JJ function_NN in_IN other_JJ species_NNS ._. In_IN order_NN to_TO
        identify_VB naturally_RB occurring_VBG animal_NN models_NNS of_IN
        sitosterolemia_NN ,_, we_PRP previously_RB reported_VBD a_DT screen_NN of_IN 20_CD
        in-bred_JJ mouse_NN strains_NNS [_NN 14_CD ]_NN ._. This_DT screen_NN showed_VBD
        considerable_JJ genetic_JJ variation_NN at_IN these_DT loci_NN in_IN the_DT mouse_NN
        strains_NNS ,_, but_CC none_NN of_IN these_DT strains_NNS exhibited_VBN
        sitosterolemia_NN ._. However_RB ,_, a_DT literature_NN search_NN revealed_VBD that_IN
        a_DT few_JJ strains_NNS of_IN rats_NNS ,_, studied_VBD primarily_RB for_IN investigation_NN
        of_IN hypertension_NN and_CC stroke_NN ,_, have_VBP been_VBN reported_VBN to_TO be_VB
        sitosterolemic_JJ as_IN well_RB [_NN 15_CD 16_CD ]_NN ._. We_PRP hypothesised_JJ that_IN
        these_DT rat_NN strains_NNS may_MD be_VB mutated_VBN in_IN either_DT 
        Abcg_NNP 5_CD or_CC 
        Abcg_NNP 8_CD ._. Tissue_NNP (_( and_CC plasma_NN )_) plant_NN
        sterol_NN levels_NNS in_IN the_DT Wistar_NNP Kyoto_NNP (_( WKY_NNP )_) rat_NN ,_, the_DT
        spontaneously_RB hypertensive_JJ rat_NN (_( SHR_NNP )_) and_CC the_DT stroke-prone_JJ
        spontaneously_RB hypertensive_JJ rat_NN (_( SHRSP_NNP )_) were_VBD significantly_RB
        higher_JJR than_IN in_IN Wistar_NNP and_CC WKA_NNP rats_NNS fed_VBN either_CC a_DT regular_JJ
        chow_NN diet_NN or_CC diets_NNS that_WDT have_VBP higher_JJR plant_NN sterols_NNS and_CC these_DT
        were_VBD correlated_JJ with_IN increased_VBN death_NN ,_, or_CC red_JJ cell_NN hemolysis_NNS
        etc_FW ._. [_NN 15_CD 16_CD 17_CD 18_CD 19_CD 20_CD 21_CD 22_CD ]_NN ._. Dietary_NNP sterol_NN
        absorption_NN rates_NNS were_VBD increased_VBN ,_, with_IN a_DT decrease_NN in_IN sterol_NN
        excretion_NN [_NN 16_CD ]_NN ,_, characteristics_NNS similar_JJ to_TO that_DT observed_VBD
        in_IN sitosterolemic_JJ patients_NNS ._.
        In_IN this_DT study_NN ,_, we_PRP report_VBP the_DT gene_NN structure_NN
        organisation_NN ,_, cDNA_NN and_CC tissue_NN expression_NN patterns_NNS of_IN rat_NN 
        Abcg_NNP 5_CD and_CC 
        Abcg_NNP 8_CD ._. Using_VBG fluorescence_NN in_IN situ_NN
        hybridization_NN ,_, the_DT rat_NN 
        STSL_NNP locus_JJ was_VBD assigned_VBN to_TO the_DT
        chromosomal_NN 6_CD q_NN 12_CD ._. Interestingly_RB ,_, a_DT cluster_NN of_IN 2_CD blood_NN
        pressure_NN (_( BP_NNP )_) quantitative_JJ trait_NN loci_NN (_( QTL_NNP )_) in_IN (_( GH_NNP ×_NN BN_NNP )_) F_NN 2_CD
        with_IN LOD_NNP scores_NNS 4_CD ._. 63_CD (_( tail_NN BP_NNP )_) and_CC 6_CD ._. 82_CD (_( intra-arterial_JJ BP_NNP )_)
        has_VBZ also_RB been_VBN reported_VBN to_TO map_VB to_TO rat_VB chromosome_NN 6_CD between_IN 
        D_NNP 6_CD Mit_NNP 3_CD and_CC 
        D_NNP 6_CD Mit_NNP 12_CD ,_, an_DT area_NN containing_VBG the_DT 
        STSL_NNP locus_JJ ._. We_PRP interrogated_VBN this_DT
        region_NN for_IN genetic_JJ variations_NNS and_CC found_VBD a_DT correlation_NN
        between_IN sitosterolemic_JJ strains_NNS and_CC a_DT missense_NN mutation_NN in_IN 
        Abcg_NNP 5_CD ._.
      
      
        Methods_NNP
        
          DNA_NNP Samples_NNP of_IN rat_NN strains_NNS
          The_DT DNA_NNP samples_NNS from_IN the_DT following_VBG rat_NN strains_NNS were_VBD
          used_VBN :_: Sprague_NNP Dawley_NNP (_( SD_NNP ,_, Charles_NNP River_NNP Laboratories_NNPS ,_,
          Wilmington_NNP ,_, MA_NNP )_) ,_, Wistar_NNP (_( Sea_NNP :_: Wistar_NNP ,_, Outbred_NNP ,_, SPF_NNP ,_, Seac_NNP
          Yoshitomi_NNP )_) and_CC WKA_NNP (_( WKA_NNP /_NN Sea_NNP ,_, inbred_JJ ,_, SPF_NNP ,_, Seac_NNP
          Yoshitomi_NNP )_) ,_, WKY_NNP (_( WKY_NNP /_NN NCrj_NNP ,_, inbred_JJ ,_, SPF_NNP ,_, Charles_NNP River_NNP
          Japan_NNP ,_, Kanagawa_NNP ,_, Japan_NNP or_CC Charles_NNP River_NNP ,_, Wilmington_NNP ,_, MA_NNP )_) ,_,
          SHR_NNP /_NN Crl_NNP (_( Charles_NNP River_NNP ,_, Wilmington_NNP ,_, MA_NNP )_) ,_, SHRSP_NNP
          (_( SHRSP_NNP /_NN Sea_NNP ,_, inbred_JJ ,_, SPF_NNP ,_, Seac_NNP Yoshitomi_NNP ,_, Fukuoka_NNP ,_, Japan_NNP )_) ,_,
          GH_NNP and_CC BN_NNP ._. The_DT genomic_JJ DNAs_NNP from_IN GH_NNP and_CC BN_NNP rats_NNS were_VBD a_DT
          kind_NN gift_NN from_IN Dr_NNP ._. E_NNP ._. L_NNP Harris_NNP (_( New_NNP Zealand_NNP )_) ._. The_DT liver_NN
          tissue_NN genomic_JJ DNAs_NNP from_IN SD_NNP ,_, WKY_NNP and_CC SHR_NNP rats_NNS were_VBD
          extracted_VBN by_IN digestion_NN overnight_JJ at_IN 55_CD °_NN C_NNP in_IN lysis_NNS buffer_NN
          (_( 10_CD mM_NN Tris_NNP pH_NN 8_CD ._. 0_CD ,_, 100_CD mM_NN NaCl_NNP ,_, 50_CD mM_NN EDTA_NNP ,_, 0_CD ._. 5_CD %_NN SDS_NNP and_CC
          0_CD ._. 2_CD mg_NN /_NN ml_NN proteinase_NN K_NNP )_) followed_VBN by_IN phenol-chloroform_JJ
          extraction_NN and_CC ethanol_NN precipitation_NN ._.
        
        
          Genomic_NNP analysis_NN and_CC determination_NN of_IN exon-intron_JJ
          boundaries_NNS
          Rat_NNP cDNAs_NNS for_IN 
          Abcg_NNP 5_CD and_CC 
          Abcg_NNP 8_CD were_VBD identified_VBN previously_RB by_IN
          amplification_NN of_IN these_DT sequences_NNS from_IN a_DT Sprague_NNP Dawley_NNP
          rat_NN enterocyte_NN cDNA_NN library_NN ,_, using_VBG primers_NNS located_VBN in_IN
          areas_NNS conserved_JJ between_IN mouse_NN and_CC human_JJ (_( Genbank_NNP AF_NNP 312714_CD
          and_CC AF_NNP 351785_CD respectively_RB )_) ._. For_IN 
          Abcg_NNP 5_CD ,_, the_DT first_JJ PCR_NNP fragment_NN was_VBD
          obtained_VBN by_IN PCR_NNP using_VBG primers_NNS ,_, ABCG_NNP 5_CD F_NN 4_CD ,_,
          5_CD '_POS -_: ATCCTCAAAGATGTCTCCTTGTAC-_NNP 3_CD '_POS ,_, and_CC ABCG_NNP 5_CD R_NN 3_CD ,_,
          5_CD '_POS -_: TCCTGACTCTCCTGGTCGCT-_NNP 3_CD '_'' ._. For_IN 
          Abcg_NNP 8_CD cDNA_NN sequences_NNS ,_, the_DT primers_NNS ,_,
          F_NN 11_CD 5_CD '_POS -_: AGATGCTGGCCATCATAGGG-_NNP 3_CD '_POS and_CC R_NN 13_CD
          5_CD '_POS -_: GATGGAGAAGGTGAAGTTGCC-_NNP 3_CD '_POS ,_, were_VBD used_VBN to_TO amplify_VB rat_NN 
          Abcg_NNP 8_CD cDNA_NN fragments_NNS ._. These_DT
          products_NNS were_VBD sequenced_JJ and_CC used_VBN to_TO design_VB primers_NNS
          specific_JJ for_IN rat_NN cDNA_NN and_CC a_DT rat_NN intestinal_NN cDNA_NN library_NN
          was_VBD screened_VBD by_IN anchor_NN PCR_NNP ._.
          Direct_NNP sequencing_VBG of_IN the_DT PCR_NNP products_NNS led_VBN to_TO the_DT
          identification_NN of_IN rat_NN cDNA_NN sequence_NN and_CC allowed_VBN for_IN
          design_NN of_IN rat_NN specific_JJ primers_NNS (_( Table_NNP 1_CD ,_, see_VBP Additional_JJ
          file_NN 1_LS )_) ._. Based_VBN upon_IN the_DT structure_NN of_IN mouse_NN genes_NNS ,_,
          putative_JJ rat-specific_JJ exonic_JJ primers_NNS were_VBD designed_VBN and_CC
          used_VBN to_TO amplify_VB rat_NN genomic_JJ regions_NNS as_RB previously_RB
          described_VBD ._. All_DT PCR_NNP products_NNS were_VBD directly_RB sequenced_JJ and_CC
          both_DT strands_NNS were_VBD sequenced_JJ as_IN a_DT routine_NN ._. The_DT complete_JJ
          rat_NN genomic_JJ sequences_NNS have_VBP been_VBN deposited_VBN with_IN GenBank_NNP
          (_( AY_NNP 145899_CD )_) ._.
          Additional_JJ File_NNP 1_CD
          Table_NNP 1_CD shows_VBZ the_DT primer_NN sequences_NNS used_VBN for_IN PCR_NNP
          amplification_NN of_IN genomic_JJ fragement_NN of_IN the_DT rat_NN 
          STSL_NNP region_NN ._.
          Click_NNP here_RB for_IN file_NN
        
        
          Chromosomal_NNP localisation_NN by_IN fluorescence_NN in_IN situ_NN
          hybridization_NN (_( FISH_NNP )_)
          For_IN FISH_NNP analysis_NN ,_, metaphase_NN chromosomes_NNS were_VBD prepared_VBN
          from_IN rat_NN embryo_NN fibroblasts_NNS ._. The_DT cells_NNS were_VBD cultured_JJ in_IN
          DMEM_NNP medium_NN at_IN 37_CD °_NN C_NNP for_IN 2_CD days_NNS and_CC treated_VBN with_IN 0_CD ._. 05_CD
          μg_NN /_NN ml_NN colcemid_NN for_IN 45_CD min_NN ._. The_DT cells_NNS were_VBD harvested_VBN by_IN
          mitotic_JJ shake-off_JJ and_CC resuspended_JJ in_IN 0_CD ._. 075_CD M_NNP KCl_NNP at_IN room_NN
          temperature_NN for_IN 10_CD min_NN ._. Fixation_NNP was_VBD carried_VBN out_IN as_IN
          described_VBN previously_RB [_NN 23_CD ]_NN ._.
          Fluorescence_NNP in_IN situ_NN hybridization_NN (_( FISH_NNP )_) was_VBD
          performed_VBN essentially_RB according_VBG to_TO Pinkel_NNP et_CC al_NN [_NN 24_CD ]_NN
          with_IN minor_JJ modifications_NNS [_NN 25_CD ]_NN ._. The_DT rat_NN sequences_NNS used_VBN
          for_IN FISH_NNP labelling_VBG were_VBD amplified_VBN genomic_JJ DNA_NNP fragments_NNS (_(
          
          Abcg_NNP 5_CD exons_NNS 6_CD -_: 10_CD ,_, primers_NNS RG_NNP 5_CD -_: F_NN 6_CD
          and_CC RG_NNP 5_CD -_: R_NN 10_CD ,_, and_CC 
          Abcg_NNP 8_CD exons_NNS 4_CD -_: 13_CD ,_, primers_NNS RG_NNP 8_CD -_: F_NN 4_CD
          and_CC RG_NNP 8_CD -_: R_NN 13_CD ,_, Table_NNP 1_CD ,_, see_VBP Additional_JJ file_NN 1_LS )_) ._. The_DT two_CD
          gene_NN fragments_NNS were_VBD labelled_JJ separately_RB with_IN
          digoxigenin-_NN 11_CD -_: dUTP_NN (_( Boehringer_NNP Mannheim_NNP ,_, Germany_NNP )_) by_IN
          nick-translation_JJ (_( Life_NNP Technologies_NNPS Inc_NNP ._. ,_, Gaithersburg_NNP ,_,
          MD_NNP )_) ._. Appropriate_NNP length_NN (_( 50_CD to_TO 500_CD bp_NN )_) of_IN the_DT nick_NN
          translated_VBN fragments_NNS was_VBD monitored_VBN by_IN checking_VBG the_DT
          nick-translation_JJ products_NNS on_IN a_DT 1_CD %_NN agarose_NN gel_NN ._. The_DT two_CD
          gene_NN fragments_NNS were_VBD precipitated_VBD separately_RB using_VBG 800_CD ng_NN
          of_IN labelled_JJ DNA_NNP with_IN 20_CD μg_NN unlabeled_JJ rat_NN C_NNP 
          o_NN t_NN 1_CD DNA_NNP ,_, which_WDT was_VBD included_VBN in_IN order_NN
          to_TO suppress_VB probe_NN hybridization_NN to_TO repetitive_JJ sequences_NNS ._.
          The_DT probe_NN DNA_NNP mixtures_NNS were_VBD ethanol_NN precipitated_VBD and_CC
          dissolved_VBN in_IN hybridization_NN buffer_NN (_( 50_CD %_NN formamide_NN ,_, 2_CD ×_NN
          SSC_NNP ,_, 10_CD %_NN dextran_NN sulphate_NN )_) ._. After_IN denaturation_NN ,_, the_DT
          highly_RB repetitive_JJ sequences_NNS in_IN the_DT probe_NN mixture_NN DNA_NNP were_VBD
          allowed_VBN to_TO bind_NN to_TO the_DT C_NNP 
          o_NN t_NN 1_CD DNA_NNP (_( 10_CD min_NN at_IN 37_CD °_NN C_NNP )_) ._. The_DT probe_NN
          mixtures_NNS were_VBD then_RB applied_VBN to_TO rat_VB fibroblast_NN metaphase_NN
          chromosome_NN slides_NNS (_( previously_RB denatured_JJ at_IN 73_CD °_NN C_NNP for_IN 2_CD min_NN
          in_IN 70_CD %_NN formamide_NN ,_, 2_CD ×_NN SSC_NNP )_) ._. Hybridization_NNP was_VBD allowed_VBN to_TO
          proceed_VB in_IN a_DT moist_NN chamber_NN for_IN 70_CD h_NN at_IN 37_CD °_NN C_NNP ._.
          Subsequently_RB ,_, the_DT slides_NNS were_VBD washed_VBN for_IN 15_CD min_NN at_IN 45_CD °_NN C_NNP
          in_IN 55_CD %_NN formamide_NN ,_, 2_CD ×_NN SSC_NNP ,_, and_CC then_RB in_IN 2_CD ×_NN SSC_NNP (_( pH_NN 7_CD ._. 0_CD )_)
          at_IN 43_CD °_NN C_NNP for_IN 9_CD min_NN ._. The_DT labelled_JJ probe_NN molecules_NNS were_VBD
          detected_VBN with_IN rhodamine_NN anti-digoxigenin_JJ (_( Oncor_NNP ,_, Inc_NNP ._. ,_,
          Gaithersburg_NNP ,_, MD_NNP )_) and_CC the_DT slides_NNS were_VBD washed_VBN 3_CD times_NNS in_IN
          PBS_NNP and_CC 0_CD ._. 1_CD %_NN Nonidet_NNP NP-_NNP 40_CD ._. Finally_RB ,_, chromosome_NN spreads_NNS
          were_VBD counterstained_JJ with_IN 4_CD ,_, 6_CD -_: diamino-_NN 2_CD -_: phenylindole_NN
          (_( DAPI_NNP ,_, 0_CD ._. 5_CD μg_NN /_NN ml_NN )_) in_IN an_DT antifade_NN solution_NN (_( Vectashield_NNP ®_NN ,_,
          Vector_NNP Laboratories_NNPS ,_, Inc_NNP ._. ,_, Burlingame_NNP ,_, CA_NNP )_) ._. The_DT images_NNS
          were_VBD captured_VBN using_VBG the_DT LEICA_NNP DM_NNP RXA_NNP in_IN combination_NN with_IN
          the_DT Q-FISH_NNP software_NN for_IN microphotography_NN ._.
        
        
          Tissue_NNP expression_NN of_IN Abcg_NNP 5_CD and_CC Abcg_NNP 8_CD
          A_DT rat_NN multiple_JJ tissue_NN Northern_NNP blot_NN (_( Origene_NNP
          Technologies_NNPS ,_, Rockville_NNP ,_, MD_NNP )_) containing_VBG immobilised_JJ poly_RB
          A_DT +_NN mRNA_NN from_IN Sprague_NNP Dawley_NNP rat_NN was_VBD used_VBN ._. Rat_NNP sterolin_NN
          cDNA_NN probes_NNS were_VBD labelled_JJ and_CC hybridization_NN and_CC washing_VBG
          steps_NNS were_VBD performed_VBN as_IN described_VBN previously_RB [_NN 26_CD ]_NN ._.
          Total_JJ tissue_NN RNAs_NNP were_VBD extracted_VBN from_IN multiple_JJ tissues_NNS
          from_IN a_DT Sprague_NNP Dawley_NNP rat_NN using_VBG Trizol_NNP reagent_NN as_IN
          described_VBN previously_RB ._. Random_NNP hexamers_NNS were_VBD used_VBN as_IN
          primers_NNS for_IN reverse_NN transcription_NN of_IN 2_CD μg_NN of_IN rat_NN RNA_NNP from_IN
          the_DT multiple_JJ tissues_NNS ._. The_DT primers_NNS were_VBD annealed_JJ to_TO
          template_NN at_IN 25_CD °_NN C_NNP for_IN 10_CD min_NN ,_, and_CC the_DT reaction_NN were_VBD
          incubated_JJ at_IN 53_CD °_NN C_NNP for_IN 1_CD h_NN in_IN the_DT presence_NN of_IN Superscript_NNP
          Reverse_VBP transcriptase_NN ,_, 5_CD mM_NN dNTP_NN mix_NN and_CC RN_NNP '_POS ase_NN Out_IN
          inhibitor_NN ._. The_DT rat_NN 
          Abcg_NNP 5_CD -_: specific_JJ primers_NNS (_( RG_NNP 5_CD c-_NN F_NN 1_CD
          and_CC RG_NNP 5_CD Fc-_NNP R_NNP 1_LS )_) ,_, 
          Abcg_NNP 8_CD -_: specific_JJ primers_NNS (_( RG_NNP 8_CD c-_NN F_NN 1_CD
          and_CC RG_NNP 8_CD c-_NN R_NN 1_LS )_) and_CC β-actin_JJ primers_NNS (_( sense_NN :_:
          5_CD '_POS -_: CTACGTCGCCCTGGACTTCGAGC-_NNP 3_CD '_POS ,_, antisense_NN :_:
          5_CD '_POS -_: GATGGAGCCGCCGATCCACACGG-_NNP 3_CD '_POS )_) were_VBD used_VBN for_IN further_JJ PCR_NNP
          amplification_NN (_( an_DT initial_NN denaturation_NN at_IN 94_CD °_NN C_NNP for_IN 3_CD min_NN ,_,
          35_CD cycles_NNS of_IN PCR_NNP amplification_NN with_IN each_DT cycle_NN consisting_VBG
          of_IN 30_CD min_NN at_IN 94_CD °_NN C_NNP ,_, 45_CD s_VBZ at_IN 60_CD °_NN C_NNP ,_, and_CC 2_CD min_NN at_IN 72_CD °_NN C_NNP ,_,
          followed_VBN by_IN an_DT extension_NN step_NN of_IN 72_CD °_NN C_NNP for_IN 5_CD min_NN )_) ._. The_DT
          resultant_JJ PCR_NNP products_NNS were_VBD gel-purified_JJ and_CC
          sequenced_JJ ._.
        
        
          Real-_NNP Time_NNP PCR_NNP
          For_IN quantitation_NN ,_, real-time_JJ PCR_NNP was_VBD employed_VBN ._. Primers_NNP
          used_VBD were_VBD based_VBN upon_IN previously_RB published_VBN mouse_NN primer_NN
          sets_NNS [_NN 27_CD 28_CD ]_NN ,_, or_CC designed_VBD using_VBG MacVector_NNP from_IN cDNA_NN
          sequences_NNS between_IN exons_NNS ,_, avoiding_VBG the_DT amplification_NN of_IN
          potentially_RB contaminating_VBG genomic_JJ DNA_NNP in_IN the_DT total_JJ RNA_NNP
          sample_NN (_( Table_NNP 3_LS )_) ._. Samples_NNP of_IN total_JJ RNA_NNP (_( 2_CD μg_NN )_) from_IN rat_NN
          livers_NNS were_VBD reverse_VB transcribed_JJ according_VBG to_TO the_DT
          SuperScript_NNP '_POS First-_NNP Strand_NNP Synthesis_NNP System_NNP (_( Invitrogen_NNP ,_,
          Carlsbad_NNP ,_, CA_NNP )_) using_VBG random_JJ hexamers_NNS with_IN a_DT final_JJ volume_NN
          of_IN 20_CD μl_NN ._. Real-time_NNP PCR_NNP was_VBD performed_VBN on_IN a_DT PE_NNP Biosystems_NNP
          GeneAmp_NNP 5700_CD sequence_NN Detection_NNP System_NNP (_( Forest_NNP City_NNP ,_, CA_NNP )_) ._.
          Standard_JJ reaction_NN volume_NN was_VBD 10_CD μl_NN and_CC contained_VBD 1_CD X_NNP
          QuantiTect_NNP SYBR_NNP Green_NNP PCR_NNP master_NN mix_NN (_( Qiagen_NNP ,_, Valencia_NNP ,_,
          CA_NNP )_) ,_, 0_CD ._. 002_CD U_NNP AmpErase_NNP UNG_NNP enzyme_NN (_( PE_NNP Biosystems_NNP ,_, Forest_NNP
          City_NNP ,_, CA_NNP )_) ,_, 0_CD ._. 7_CD μl_NN of_IN cDNA_NN template_NN and_CC 100_CD -_: 500_CD nM_NN of_IN
          oligonucleotide_NN primers_NNS ._. Initial_JJ steps_NNS of_IN RT-PCR_NNP were_VBD 2_CD
          minutes_NNS at_IN 50_CD °_NN C_NNP for_IN UNG_NNP erase_VB activation_NN ,_, followed_VBN by_IN a_DT
          15_CD minute_NN hold_NN at_IN 95_CD °_NN C_NNP ._. Cycles_NNP (_( n_NN =_SYM 40_CD )_) consisted_VBD of_IN a_DT 15_CD
          second_JJ melt_VB at_IN 95_CD °_NN C_NNP ,_, followed_VBN by_IN a_DT 1_CD minute_NN
          annealing_VBG /_NN extension_NN at_IN 60_CD °_NN C_NNP ._. The_DT final_JJ step_NN was_VBD a_DT 60_CD °_NN C_NNP
          incubation_NN for_IN 1_CD minute_NN ._. All_DT reactions_NNS were_VBD performed_VBN in_IN
          triplicate_NN ._. Threshold_NNP cycle_NN (_( CT_NNP )_) analysis_NN of_IN all_DT samples_NNS
          was_VBD set_VBN at_IN 0_CD ._. 5_CD relative_JJ fluorescence_NN units_NNS ._.
          The_DT relative_JJ amounts_NNS of_IN 
          Abcg_NNP 5_CD ,_, 
          Abcg_NNP 8_CD ,_, Cyp_NNP 7_CD a_DT 1_CD ,_, HMG-CoA_NNP reductase_NN ,_,
          and_CC Srebp-_NNP 2_CD message_NN from_IN rat_NN liver_NN samples_NNS used_VBN in_IN
          real-time_JJ RT-PCR_NNP were_VBD normalised_JJ to_TO GAPDH_NNP expression_NN
          levels_NNS to_TO compensate_VB for_IN variations_NNS in_IN input_NN RNA_NNP amounts_NNS ._.
          The_DT data_NNS were_VBD analysed_JJ using_VBG the_DT comparative_JJ threshold_NN
          cycle_NN method_NN (_( CT_NNP )_) method_NN ._. Briefly_NNP ,_, the_DT CT_NNP values_NNS were_VBD
          averaged_VBN ,_, from_IN triplicate_NN determinations_NNS ,_, defining_VBG a_DT Δ-CT_JJ
          value_NN calculated_VBN by_IN taking_VBG the_DT average_JJ CT_NNP of_IN the_DT gene_NN of_IN
          interest_NN and_CC subtracting_VBG it_PRP from_IN the_DT average_JJ CT_NNP of_IN GAPDH_NNP ._.
          The_DT ΔΔ-CT_JJ was_VBD calculated_VBN by_IN subtracting_VBG the_DT average_JJ
          Δ-CT_JJ (_( calibrator_NN )_) values_NNS from_IN the_DT Δ-CT_JJ (_( sample_NN )_) ._. The_DT
          relative_JJ quantification_NN was_VBD then_RB calculated_VBN by_IN the_DT
          expression_NN 2_CD (_( AverageΔΔCT_NNP )_) ._. The_DT mRNA_NN quantity_NN for_IN the_DT
          calibrator_NN (_( SD_NNP samples_NNS )_) is_VBZ expressed_VBN as_IN 1_CD X_NNP sample_NN and_CC all_DT
          other_JJ quantities_NNS are_VBP expressed_VBN as_IN a_DT fold_VB difference_NN
          relative_JJ to_TO the_DT calibrator_NN (_( SD_NNP samples_NNS )_) ._.
        
        
          Total_JJ membrane_NN protein_NN preparations_NNS
          Approximately_RB 500_CD mg_NN of_IN liver_NN tissue_NN cut_NN into_IN small_JJ
          pieces_NNS was_VBD homogenised_JJ in_IN ice_NN cold_JJ lysis_NNS buffer_NN (_( 5_CD mM_NN
          Tris-p_NNP H_NNP 7_CD ._. 5_LS ,_, 250_CD mM_NN sucrose_NN with_IN protease_NN inhibitors_NNS PMSF_NNP ,_,
          Leupeptin_NNP ,_, Aprotinin_NNP )_) by_IN a_DT dounce_NN homogenizer_NN times_NNS 10_CD
          strokes_NNS ._. Samples_NNP were_VBD then_RB subjected_VBN to_TO centrifugation_NN
          1000_CD g_SYM for_IN 10_CD minutes_NNS at_IN 4_CD °_NN C_NNP ._. The_DT supernatant_NN was_VBD saved_VBN ._.
          The_DT pellet_NN was_VBD resuspended_JJ and_CC subjected_VBN to_TO dounce_NN
          homogenisation_NN by_IN 10_CD strokes_NNS ,_, centrifuged_JJ at_IN 1000_CD g_SYM for_IN 10_CD
          minutes_NNS at_IN 4_CD °_NN C_NNP and_CC this_DT step_NN was_VBD repeated_VBN once_RB more_JJR ._. The_DT
          supernatants_NNS from_IN all_DT three_CD steps_NNS were_VBD pooled_VBN and_CC
          subjected_VBN to_TO ultracentrifugation_NN at_IN 100_CD ,_, 000_CD g_SYM for_IN 40_CD
          minutes_NNS at_IN 4_CD °_NN C_NNP ,_, and_CC the_DT pellet_NN was_VBD resuspended_JJ in_IN 25_CD mM_NN
          Tris-p_NNP H_NNP 7_CD ._. 5_LS ,_, 150_CD mM_NN NaCl_NNP ,_, 0_CD ._. 1_CD %_NN TritonX-_NNP 100_CD and_CC 0_CD ._. 1_CD %_NN SDS_NNP ,_,
          by_IN passaging_VBG through_IN a_DT 25_CD -_: gauge_VB needle_NN ._. Membrane_NNP protein_NN
          concentrations_NNS were_VBD determined_VBN by_IN a_DT colorimetric_JJ assay_NN
          according_VBG to_TO manufacturer_NN 's_POS protocol_NN (_( BioRad_NNP ,_, Hercules_NNP ,_,
          CA_NNP )_) and_CC 20_CD μg_NN of_IN total_JJ membrane_NN proteins_NNS resolved_VBN by_IN 7_CD ._. 5_CD %_NN
          SDS_NNP acrylamide_NN gel_NN ._.
        
        
          Immunoblotting_NNP and_CC Immunolocalization_NNP
          Proteins_NNPS resolved_VBN by_IN SDS-PAGE_NNP were_VBD transferred_VBN to_TO
          nitrocellulose_NN membranes_NNS and_CC the_DT membranes_NNS blocked_VBN for_IN 2_CD
          hours_NNS in_IN 5_CD %_NN dry_JJ milk_NN in_IN PBS-T_NNP (_( Phosphate_NNP Buffered_NNP saline_NN
          and_CC 0_CD ._. 1_CD %_NN Tween_NNP 20_CD )_) ._. Blots_NNP were_VBD then_RB probed_JJ with_IN a_DT primary_JJ
          rabbit_NN anti-peptide_JJ (_( 116_CD -_: VNGCELRRDQFQDCCVSYLLQS-_NNP 136_CD )_)
          antibody_NN against_IN rat_NN sterolin-_NN 1_CD (_( 1_CD :_: 1000_CD dilution_NN )_)
          overnight_JJ at_IN 4_CD °_NN C_NNP ._. The_DT blot_NN was_VBD washed_VBN once_RB for_IN 5_CD minutes_NNS
          in_IN PBS-T_NNP ,_, incubated_JJ with_IN goat-anti-rabbit_JJ conjugated_JJ HRP_NNP
          (_( 1_CD :_: 10000_CD dilution_NN )_) for_IN 1_CD hour_NN ,_, washed_VBN for_IN 5_CD minutes_NNS in_IN
          PBS-T_NNP and_CC developed_VBN with_IN Western_NNP Lightning_NNP
          Chemiluminescence_NNP Reagent_NNP Plus_NNP (_( PerkinElmer_NNP Life_NNP
          Sciences_NNPS ,_, Inc_NNP ._. Boston_NNP ,_, MA_NNP )_) ._.
          Snap-frozen_NNP rat_NN liver_NN and_CC intestine_NN tissues_NNS were_VBD
          sectioned_JJ to_TO 8_CD μm_NN thickness_NN using_VBG a_DT cryotome_NN (_( Bright_NNP )_) ,_,
          air-dried_JJ for_IN 30_CD min_NN and_CC keep_VB at_IN -_: 80_CD °_NN C_NNP until_IN used_VBN ._. The_DT
          slides_NNS were_VBD stained_JJ with_IN hematoxylin_NN ._. Fixation_NNP was_VBD
          performed_VBN by_IN incubating_VBG samples_NNS for_IN 10_CD min_NN with_IN cooled_VBN
          methanol_NN at_IN -_: 20_CD °_NN C_NNP and_CC washed_VBN with_IN PBS_NNP three_CD times_NNS ._. The_DT
          slides_NNS were_VBD treated_VBN with_IN blocking_VBG solution_NN (_( 10_CD %_NN goat_NN
          serum_NN in_IN 0_CD ._. 1_CD M_NNP glycine_NN /_NN PBS_NNP )_) for_IN 30_CD min_NN ._. ,_, primary_JJ antibody_NN
          applied_VBN and_CC incubated_JJ overnight_JJ at_IN 4_CD °_NN C_NNP ._. The_DT slides_NNS were_VBD
          washed_VBN with_IN PBS_NNP and_CC secondary_JJ antibody_NN (_( goat-anti-rabbit_JJ
          FITC_NNP conjugated_JJ )_) was_VBD applied_VBN for_IN 20_CD -_: 30_CD min_NN at_IN room_NN
          temperature_NN ,_, washed_VBN and_CC the_DT signals_NNS captured_VBN and_CC analyzed_VBN
          using_VBG an_DT Olympus_NNP BX-_NNP 50_CD microscope_NN with_IN Fluoview_NNP software_NN ._.
          The_DT fluorescent_NN stained_JJ images_NNS were_VBD observed_VBN under_IN blue_JJ
          filter_NN excitation_NN and_CC capture_VB excitation_NN images_NNS at_IN 488_CD nm_NN
          wavelength_NN ._.
        
        
          Nucleotide_NNP polymorphisms_NNS in_IN Abcg_NNP 5_CD and_CC
          Abcg_NNP 8_CD genes_NNS
          Direct_NNP sequencing_VBG of_IN PCR_NNP amplified_VBN genomic_JJ fragments_NNS
          was_VBD performed_VBN as_IN described_VBN previously_RB [_NN 11_CD ]_NN ._. The_DT 5_CD '_POS
          flanking_VBG region_NN ,_, all_PDT the_DT exons_NNS and_CC the_DT 3_CD '_POS UTR_NNP region_NN ,_, as_RB
          well_RB as_IN the_DT introns_NNS of_IN 
          Abcg_NNP 5_CD and_CC 
          Abcg_NNP 8_CD with_IN size_NN less_JJR than_IN 1_CD Kb_NNP ,_,
          were_VBD individually_RB amplified_VBN using_VBG primers_NNS ,_, as_IN described_VBN
          in_IN Table_NNP 2_CD ._. The_DT amplified_VBN PCR_NNP products_NNS were_VBD sequenced_JJ by_IN
          the_DT use_NN of_IN an_DT automated_VBN capillary_JJ sequencer_NN ._. The_DT Sprague_NNP
          Dawley_NNP nucleotide_NN sequence_NN of_IN 
          Abcg_NNP 5_CD and_CC 
          Abcg_NNP 8_CD was_VBD regarded_VBN as_IN wild-type_JJ ._.
          Comparisons_NNP to_TO mammalian_JJ sterolins_NNS (_( GenBank_NNP accession_NN
          Nos_NNP ._. AF_NNP 312713_CD ,_, AF_NNP 312714_CD ,_, AF_NNP 312715_CD ,_, AF_NNP 324494_CD AF_NNP 324495_CD ,_,
          AF_NNP 351785_CD )_) as_RB well_RB as_IN Fugu_NNP (_( GenBank_NNP No_UH ._. CAAB_NNP 01001529_CD )_) ,_, was_VBD
          made_VBN using_VBG ClustalW_NNP [_NN 29_CD ]_NN ._.
        
      
      
        Results_NNS
        
          Genomic_NNP organisation_NN and_CC chromosome_NN mapping_NN of_IN the_DT
          rat_NN STSLlocus_NNP
          Rat_NNP cDNA_NN sequences_NNS for_IN 
          Abcg_NNP 5_CD and_CC 
          Abcg_NNP 8_CD were_VBD isolated_VBN and_CC
          characterized_VBN as_IN indicated_VBN in_IN Methods_NNP ._. Based_VBN upon_IN the_DT
          known_VBN conservation_NN between_IN the_DT murine_NN and_CC human_JJ 
          STSL_NNP loci_NN [_NN 14_CD ]_NN ,_, we_PRP designed_VBD
          oligonucleotides_NNS in_IN putative_JJ exonic_JJ regions_NNS and_CC used_VBN PCR_NNP
          amplification_NN of_IN rat_NN genomic_JJ region_NN to_TO characterise_NN the_DT
          genome_NN organisation_NN ._. Figure_NN 1_CD shows_VBZ a_DT summary_NN composite_NN of_IN
          the_DT genomic_JJ organisation_NN ._. The_DT intron-exon_JJ boundary_NN
          sequences_NNS are_VBP indicated_VBN in_IN Table_NNP 3_CD ._. In_IN keeping_VBG with_IN the_DT
          human_NN and_CC mouse_NN 
          STSL_NNP loci_NN ,_, the_DT rat_NN 
          Abcg_NNP 5_CD and_CC 
          Abcg_NNP 8_CD genes_NNS are_VBP arranged_VBN in_IN a_DT
          head-to-head_RB configuration_NN ,_, with_IN a_DT distance_NN of_IN 379_CD bp_NN
          separating_VBG their_PRP$ respective_JJ initiation_NN codons_NNS ._. The_DT exact_JJ
          start_NN transcriptional_NN sites_NNS for_IN either_DT gene_NN has_VBZ not_RB been_VBN
          definitively_RB established_VBN ._. Comparison_NNP of_IN the_DT DNA_NNP sequence_NN
          of_IN isolated_VBN cDNAs_NNS ,_, as_RB well_RB as_IN the_DT polypeptide_NN sequence_NN
          with_IN human_NN and_CC mouse_NN sequences_NNS revealed_VBD a_DT very_RB high_JJ
          degree_NN of_IN homology_NN (_( >_NN 80_CD %_NN )_) ._. To_TO assign_VB the_DT chromosomal_NN
          location_NN ,_, we_PRP performed_VBD FISH_NNP analyses_NNS ,_, and_CC we_PRP were_VBD able_JJ to_TO
          unambiguously_RB map_VB the_DT rat_NN 
          STSL_NNP locus_JJ to_TO chromosome_NN 6_CD q_NN 12_CD (_( Fig_NNP ._.
          2_LS )_) ._. There_EX is_VBZ specific_JJ labelling_VBG of_IN both_DT chromatids_NNS of_IN
          both_DT homologues_NNS of_IN rat_NN chromosome_NN (_( RNO_NNP )_) 6_CD (_( Fig_NNP ._. 2_LS Aand_NNP
          2_CD B_NNP )_) ._. Based_VBN on_IN the_DT DAPI-banding_NNP pattern_NN the_DT 
          Abcg_NNP 5_CD and_CC 
          Abcg_NNP 8_CD genes_NNS were_VBD sub-localized_JJ to_TO
          RNO_NNP 6_CD q_NN 12_CD ._. The_DT 
          STSL_NNP locus_JJ was_VBD mapped_VBN to_TO the_DT same_JJ
          position_NN as_IN shown_VBN by_IN the_DT diagrammatic_JJ representation_NN of_IN
          the_DT rat_NN Chr_NNP ._. 6_CD as_IN shown_VBN in_IN Fig_NNP ._. 2_LS ._. The_DT human_JJ 
          ABCG_NNP 5_CD and_CC 
          ABCG_NNP 8_CD genes_NNS are_VBP present_JJ in_IN a_DT group_NN
          of_IN 18_CD genes_NNS 
          ABCG_NNP 5_CD ,_, ABCG_NNP 8_CD ,_, SLC_NNP 8_CD A_DT 1_CD ,_, PRKR_NNP ,_, GCKR_NNP ,_, KHK_NNP ,_,
          PPP_NNP 1_CD CB_NNP ,_, APOB_NNP ,_, POMC_NNP 1_CD ,_, SDC_NNP 1_CD ,_, MYCN_NNP ,_, DDX_NNP 1_CD ,_, VSNL_NNP 1_CD ,_, RRM_NNP 2_CD ,_, ODC_NNP 1_CD ,_,
          ID_NNP 2_CD ,_, TPO_NNP and_CC 
          ACP_NNP 1_CD in_IN the_DT region_NN HSA_NNP 2_CD p_NN 21_CD -_: p_NN 25_CD ,_, and_CC
          this_DT group_NN is_VBZ also_RB present_JJ on_IN RNO_NNP 6_CD ._. Thus_RB ,_, the_DT 
          ABCG_NNP 5_CD and_CC 
          ABCG_NNP 8_CD genes_NNS fit_VBP into_IN a_DT group_NN of_IN
          genes_NNS that_WDT are_VBP syntenic_JJ both_DT in_IN HSA_NNP 2_CD and_CC in_IN RNO_NNP 6_CD ._. A_DT
          conserved_JJ segment_NN between_IN HSA_NNP 2_CD ,_, RNO_NNP 6_CD ,_, and_CC MMU_NNP 17_CD on_IN
          RNO_NNP 6_CD q_NN 11_CD -_: q_NN 16_CD has_VBZ been_VBN demonstrated_VBN by_IN Zoo-_NNP FISH_NNP analysis_NN
          and_CC gene_NN mapping_NN data_NNS ,_, confirming_VBG this_DT synteny_NN [_NN 30_CD 31_CD 32_CD
          ]_NN ._.
        
        
          Expression_NNP patterns_NNS of_IN rat_NN Abcg_NNP 5_CD and_CC
          Abcg_NNP 8_CD mRNAs_NNS
          Rat_NNP 
          Abcg_NNP 5_CD and_CC 
          Abcg_NNP 8_CD mRNA_NN expression_NN patterns_NNS were_VBD
          determined_VBN ,_, using_VBG a_DT commercial_JJ multiple_JJ tissue_NN poly_RB A_DT
          +_NN Northern_NNP filter_NN ._. Expression_NNP appeared_VBD mainly_RB to_TO be_VB
          confined_VBN to_TO the_DT liver_NN (_( Fig_NNP ._. 3_LS A_DT )_) ,_, with_IN dominant_JJ
          transcripts_NNS sizes_NNS of_IN ~_NN 2_CD ._. 5_LS kb_NN for_IN 
          Abcg_NNP 5_CD and_CC of_IN ~_NN 4_CD ._. 5_LS kb_NN for_IN 
          Abcg_NNP 8_CD ._. However_RB ,_, the_DT poly_RB A_DT +_NN RNA_NNP
          loaded_VBD onto_IN this_DT Northern_NNP blot_NN has_VBZ been_VBN adjusted_VBN to_TO
          obtain_VB an_DT identical_JJ β-actin_JJ signal_NN ,_, and_CC the_DT intestinal_NN
          RNA_NNP loaded_VBD may_MD thus_RB have_VB less_JJR enterocyte_NN RNA_NNP ._. Using_VBG a_DT
          more_RBR sensitive_JJ RT-PCR_NNP analyses_NNS of_IN RNA_NNP obtained_VBD from_IN
          different_JJ tissues_NNS confirmed_VBD that_DT rat_NN 
          Abcg_NNP 5_CD and_CC 
          Abcg_NNP 8_CD genes_NNS were_VBD expressed_VBN in_IN both_DT
          in_IN the_DT liver_NN and_CC small_JJ intestine_NN ,_, with_IN a_DT low_JJ level_NN of_IN
          expression_NN in_IN the_DT colon_NN (_( Fig_NNP ._. 3_LS B_NNP )_) ._.
          Additionally_RB ,_, while_IN screening_VBG an_DT enterocyte_NN cDNA_NN
          library_NN for_IN full_JJ length_NN cDNAs_NNS using_VBG PCR_NNP ,_, we_PRP consistently_RB
          amplified_VBN two_CD DNA_NNP products_NNS when_WRB using_VBG 
          Abcg_NNP 8_CD primers_NNS flanking_VBG exon_NN 2_CD ;_: one_CD
          of_IN the_DT expected_VBN size_NN ,_, and_CC another_DT very_RB low_JJ copy_NN product_NN
          ~_NN 60_CD bases_NNS larger_JJR ._. Direct_NNP sequencing_VBG of_IN these_DT products_NNS
          confirmed_VBD both_DT of_IN these_DT contained_VBN 
          Abcg_NNP 8_CD rat_NN cDNA_NN sequences_NNS ,_, but_CC the_DT
          larger_JJR product_NN contained_VBD a_DT 66_CD bp_NN insertion_NN ,_, resulting_VBG in_IN
          a_DT predicted_VBN in-frame_JJ addition_NN of_IN 22_CD amino_JJ acids_NNS ,_, between_IN
          exons_NNS 2_CD and_CC 3_CD ._. To_TO confirm_VB that_IN this_DT insertion_NN resulted_VBD
          from_IN an_DT alternatively_RB spliced_JJ mRNA_NN ,_, we_PRP amplified_VBN and_CC
          sequenced_JJ the_DT intragenic_JJ region_NN between_IN exons_NNS 2_CD and_CC 3_CD and_CC
          identified_VBD a_DT 66_CD bp_NN exon_NN (_( exon_NN 2_CD b_SYM )_) ,_, flanked_JJ by_IN canonical_JJ
          splice-sites_JJ (_( see_VB Table_NNP 2_CD and_CC Fig_NNP ._. 4_LS )_) ._. We_PRP next_RB screened_VBD
          total_JJ liver_NN and_CC intestinal_NN RNA_NNP ,_, using_VBG RT-PCR_NNP ,_, from_IN SD_NNP ,_,
          SHR_NNP and_CC WKY_NNP rats_NNS (_( Fig_NNP ._. 4_LS )_) ._. In_IN all_DT samples_NNS a_DT larger_JJR DNA_NNP
          fragment_NN of_IN low_JJ abundance_NN was_VBD identified_VBN (_( Fig_NNP ._. 4_LS )_) and_CC
          direct_JJ sequencing_VBG showed_VBN that_IN these_DT fragments_NNS contained_VBD
          exon_NN 2_CD b_SYM sequences_NNS (_( data_NNS not_RB shown_VBN )_) ._. It_PRP is_VBZ not_RB established_VBN
          whether_IN these_DT transcripts_NNS are_VBP a_DT result_NN of_IN aberrant_NN
          splicing_VBG ,_, or_CC are_VBP translated_VBN and_CC code_NN for_IN a_DT slightly_RB
          larger_JJR sterolin-_NN 2_CD ._. Careful_NNP interrogation_NN of_IN the_DT mouse_NN and_CC
          human_JJ genomic_JJ sequences_NNS did_VBD not_RB identify_VB any_DT homologous_RB
          sequences_NNS ,_, suggesting_VBG this_DT is_VBZ unique_JJ to_TO the_DT rat_NN ._.
          Additionally_RB ,_, both_DT the_DT mouse_NN and_CC human_JJ 
          Abcg_NNP 8_CD genes_NNS have_VBP alternatively_RB
          spliced_JJ mRNA_NN ,_, involving_VBG a_DT CAG_NNP repeat_NN at_IN exon_NN 2_CD and_CC exon_NN 8_CD
          splice_NN acceptor_NN sites_NNS respectively_RB [_NN 12_CD 14_CD ]_NN ._. However_RB ,_,
          despite_IN the_DT presence_NN of_IN such_JJ a_DT repeat_NN at_IN the_DT rat_NN exon_NN 2_CD
          splice_NN acceptor_NN site_NN for_IN 
          Abcg_NNP 8_CD (_( Table_NNP 2_LS )_) ,_, none_NN of_IN the_DT rat_NN
          mRNAs_NNS showed_VBD any_DT heterogeneity_NN of_IN splice-site_JJ selection_NN
          at_IN this_DT site_NN ._.
        
        
          Hypertensive_NNP rats_NNS have_VBP sitosterolemia_NN and_CC a_DT
          mis-sense_JJ change_NN in_IN Abcg_NNP 5_CD
          A_DT number_NN of_IN different_JJ groups_NNS have_VBP reported_VBN that_IN
          genetically_RB hypertensive_JJ strains_NNS of_IN rats_NNS (_( SHR_NNP ,_, SHRSP_NNP ,_,
          WKY_NNP )_) have_VBP elevated_VBD levels_NNS of_IN plasma_NN sitosterol_NN [_NN 15_CD 16_CD 17_CD
          18_CD 19_CD 20_CD 21_CD 22_CD ]_NN ._. Although_IN the_DT WKY_NNP strain_NN is_VBZ not_RB
          considered_VBN hypertensive_JJ ,_, dietary_JJ alterations_NNS involving_VBG
          plant_NN sterols_NNS appear_VBP to_TO increase_VB blood_NN pressure_NN in_IN this_DT
          strain_NN [_NN 21_CD ]_NN ._. We_PRP screened_VBD two_CD commercially_RB available_JJ
          hypertensive_JJ rats_NNS ,_, as_RB well_RB as_IN a_NNP '_POS genetically_RB
          hypertensive_JJ '_POS strain_NN ,_, GH_NNP ,_, for_IN plasma_NN plant_NN sterol_NN levels_NNS
          and_CC compared_VBD these_DT to_TO two_CD control_NN strains_NNS ,_, Sprague-_NNP Dawley_NNP
          and_CC Wistar_NNP (_( Table_NNP 4_LS )_) ._. Our_PRP$ analyses_NNS confirmed_VBD that_IN WKY_NNP ,_,
          and_CC SHR_NNP are_VBP sitosterolemic_JJ on_IN a_DT chow_NN diet_NN ,_, but_CC neither_DT
          the_DT control_NN strains_NNS ,_, nor_CC the_DT GH_NNP rat_NN showed_VBD any_DT
          significant_JJ differences_NNS ._.
          To_TO identify_VB if_IN alterations_NNS at_IN the_DT 
          STSL_NNP locus_JJ could_MD account_VB for_IN these_DT
          observations_NNS ,_, we_PRP amplified_VBN and_CC directly_RB sequenced_JJ 
          Abcg_NNP 5_CD and_CC 
          Abcg_NNP 8_CD from_IN Wistar_NNP ,_, Sprague-_NNP Dawley_NNP ,_,
          WKY_NNP ,_, WKA_NNP ,_, GH_NNP ,_, SHR_NNP ,_, and_CC SHRSP_NNP rats_NNS ._. Table_NNP 5_CD shows_VBZ a_DT
          compilation_NN of_IN both_DT coding_VBG and_CC non-coding_JJ alterations_NNS
          detected_VBD ._. There_EX were_VBD 24_CD polymorphic_JJ changes_NNS detected_VBD in_IN 
          Abcg_NNP 5_CD and_CC 14_CD polymorphic_JJ changes_NNS in_IN
          
          Abcg_NNP 8_CD ._. However_RB ,_, only_RB one_CD
          non-synonymous_JJ nucleotide_NN change_NN ,_, G_NNP 1754_CD T_NN ,_, resulting_VBG in_IN a_DT
          conservative_JJ cysteine_NN substitution_NN for_IN glycine_NN at_IN amino_JJ
          acid_NN 583_CD (_( Gly_NNP 583_CD Cys_NNP )_) in_IN sterolin-_NN 1_CD was_VBD identified_VBN (_( Fig_NNP ._.
          5_LS A_DT )_) ._. This_NNP '_POS mutation_NN '_'' was_VBD only_RB detected_VBN in_IN SHR_NNP ,_, SHRSP_NNP and_CC
          WKY_NNP rats_NNS and_CC was_VBD present_JJ in_IN all_DT of_IN these_DT strains_NNS as_IN a_DT
          homozygous_JJ change_NN (_( Table_NNP 5_LS )_) ._. These_DT hypertensive_JJ strains_NNS
          also_RB shared_VBN uniquely_RB 4_CD other_JJ nucleotide_NN changes_NNS not_RB
          present_VBP in_IN the_DT other_JJ strains_NNS (_( Table_NNP 5_LS )_) ._. These_DT latter_JJ
          changes_NNS were_VBD confined_VBN to_TO intronic_JJ areas_NNS and_CC the_DT 3_CD '_POS UTR_NNP
          region_NN ._. Although_IN the_DT intronic_JJ changes_NNS are_VBP unlikely_JJ to_TO
          alter_VB the_DT biology_NN of_IN these_DT genes_NNS ,_, the_DT 3_CD '_POS UTR_NNP insertion_NN in_IN
          
          Abcg_NNP 8_CD mRNA_NN could_MD be_VB important_JJ ,_, if_IN
          message_NN stability_NN were_VBD affected_VBN ._. This_DT possibility_NN was_VBD not_RB
          formally_RB investigated_VBN ._.
          The_DT identified_VBN G_NNP 1754_CD T_NN (_( Gly_NNP 583_CD Cys_NNP )_) missense_NN mutation_NN of_IN
          the_DT 
          Abcg_NNP 5_CD generates_VBZ loss_NN of_IN a_DT
          restriction_NN site_NN for_IN 
          Hae_NNP III_NNP after_IN PCR_NNP amplification_NN of_IN
          exon_NN 12_CD ,_, and_CC this_DT allowed_JJ a_DT PCR-RFLP_NNP assay_NN to_TO further_VB
          confirm_VB the_DT detected_VBN change_NN (_( Figure_NN 5_CD B_NNP )_) ._. Note_VB that_IN the_DT
          DNA_NNP chosen_VBN from_IN a_DT single_JJ Wistar_NNP rat_NN was_VBD heterozygous_JJ for_IN
          almost_RB all_DT of_IN these_DT changes_NNS ._. The_DT amino_JJ acid_NN G_NNP 583_CD is_VBZ
          conserved_JJ between_IN all_DT known_VBN mammalian_JJ sterolin-_NN 1_CD proteins_NNS
          (_( Fig_NNP ._. 5_LS C_NNP )_) and_CC its_PRP$ alteration_NN may_MD have_VB functional_JJ
          consequences_NNS ,_, as_IN it_PRP is_VBZ also_RB conserved_JJ in_IN evolution_NN ,_, being_VBG
          conserved_JJ in_IN the_DT Fugu_NNP fish_NN (_( Fig_NNP ._. 5_LS C_NNP )_) ._. Fugu_NNP sterolin-_NN 1_CD
          shows_VBZ a_DT 55_CD %_NN homology_NN to_TO rat_VB sterolin-_NN 1_CD at_IN the_DT amino_JJ acid_NN
          level_NN ,_, and_CC its_PRP$ gene_NN structure_NN is_VBZ also_RB organized_VBN in_IN a_DT
          similar_JJ fashion_NN (_( data_NNS not_RB shown_VBN )_) ._. Currently_RB ,_, a_DT gap_NN in_IN the_DT
          Fugu_NNP genomic_JJ sequence_NN has_VBZ not_RB been_VBN completed_VBN that_WDT may_MD
          encode_NN for_IN exon_NN 2_CD ._. The_DT complete_JJ Fugu_NNP 
          STSL_NNP locus_JJ is_VBZ available_JJ on-line_JJ
          (_( GenBank_NNP No_UH ._. CAAB_NNP 01001529_CD )_) ._.
          In_IN 
          Abcg_NNP 8_CD ,_, a_DT large_JJ insertional_NN
          polymorphism_NN was_VBD identified_VBN in_IN exon_NN 13_CD ,_, that_WDT resulted_VBD in_IN
          the_DT insertion_NN of_IN 143_CD nucleotides_NNS in_IN the_DT 3_CD '_POS UTR_NNP
          (_( *_NN 2099_CD __NN 2100_CD ins_NNS 143_CD nt_RB )_) ._. WKY_NNP ,_, SHR_NNP ,_, SHRSP_NNP and_CC GH_NNP rats_NNS are_VBP
          homozygous_JJ ,_, Sprague_NNP Dawley_NNP and_CC WKA_NNP strains_NNS wild-type_JJ and_CC
          the_DT Wistar_NNP sample_NN heterozygous_JJ for_IN this_DT polymorphism_NN
          (_( Fig_NNP ._. 6_CD )_) ._.
        
        
          Comparison_NNP of_IN expression_NN of_IN Abcg_NNP 5_CD and_CC Abcg_NNP 8_CD in_IN
          hypertensive_JJ rat_NN strains_NNS
          Expression_NNP levels_NNS of_IN 
          Abcg_NNP 5_CD and_CC 
          Abcg_NNP 8_CD in_IN these_DT rat_NN strains_NNS were_VBD
          examined_VBN in_IN two_CD ways_NNS ._. For_IN mRNA_NN expression_NN ,_, quantitative_JJ
          real_JJ time_NN PCR_NNP was_VBD utilised_JJ ,_, and_CC for_IN protein_NN ,_, western_JJ
          blotting_VBG analyses_NNS ,_, as_RB well_RB as_IN immunohistochemistry_NN was_VBD
          employed_VBN ._. Fig_NNP ._. 7_CD shows_VBZ the_DT results_NNS of_IN the_DT real_JJ time_NN PCR_NNP
          assays_NNS of_IN liver_NN RNAs_NNP from_IN fasted_JJ animals_NNS ._. Using_VBG GAPDH_NNP
          mRNA_NN expression_NN as_IN a_DT control_NN ,_, expression_NN of_IN 
          Abcg_NNP 5_CD and_CC 
          Abcg_NNP 8_CD mRNAs_NNS appeared_VBD to_TO be_VB
          increased_VBN in_IN liver_NN from_IN SHR_NNP compared_VBD to_TO Sprague_NNP Dawley_NNP
          (_( Fig_NNP ._. 7_CD )_) ,_, the_DT message_NN for_IN Cyp_NNP 7_CD a_DT 1_CD (_( except_IN for_IN Wistar_NNP and_CC
          WKY_NNP )_) HMG_NNP CoA_NNP reductase_NN ,_, SR-B_NNP 1_CD ,_, and_CC SREBP-_NNP 2_CD (_( except_IN for_IN
          SHR_NNP )_) were_VBD relatively_RB unchanged_JJ ._. Interestingly_RB ,_, the_DT
          message_NN for_IN LDL-R_NNP was_VBD reduced_VBN in_IN both_DT WKY_NNP and_CC SHR_NNP
          livers_NNS ._.
          To_TO compare_VB protein_NN expression_NN levels_NNS of_IN the_DT sterolins_NNS ,_,
          we_PRP performed_VBD western_JJ blotting_VBG ._. A_DT reliable_JJ antibody_NN to_TO
          sterolin-_NN 1_CD was_VBD available_JJ only_RB and_CC was_VBD used_VBN to_TO probe_VB liver_NN
          microsomal_NN lysates_NNS from_IN Sprague_NNP Dawley_NNP ,_, SHR_NNP and_CC Wistar_NNP
          rats_NNS (_( Fig_NNP ._. 8_CD )_) ._. Although_IN equal_JJ amounts_NNS of_IN microsomal_NN
          protein_NN lysates_NNS were_VBD loaded_VBN from_IN the_DT livers_NNS of_IN these_DT
          different_JJ strains_NNS ,_, we_PRP consistently_RB observed_VBD that_IN the_DT
          protein_NN expression_NN patterns_NNS were_VBD always_RB different_JJ between_IN
          SHR_NNP and_CC the_DT control_NN strains_NNS (_( Fig_NNP ._. 8_CD ,_, panel_NN C_NNP ,_, cf_NN ._. tracks_VBZ
          5_CD ,_, 6_CD and_CC 8_CD )_) ._. Thus_RB ,_, all_DT of_IN the_DT data_NNS were_VBD normalised_JJ in_IN one_CD
          of_IN two_CD ways_NNS ,_, either_CC by_IN using_VBG total_JJ microsomal_NN protein_NN ,_, or_CC
          by_IN using_VBG the_DT intensity_NN of_IN transferrin_NN signal_NN ,_, after_IN
          western_JJ blotting_VBG ._. Both_DT of_IN these_DT methods_NNS gave_VBD consistent_JJ
          results_NNS and_CC indicated_VBD that_DT expression_NN of_IN 
          Abcg_NNP 5_CD was_VBD increased_VBN approximately_RB
          2_CD -_: fold_VB in_IN the_DT SHR_NNP but_CC not_RB the_DT Wistar_NNP or_CC SD_NNP (_( Fig_NNP ._. 8_CD )_) ._. To_TO
          further_VB assess_VB if_IN the_DT mutant_JJ protein_NN is_VBZ mis-targeted_JJ ,_, we_PRP
          performed_VBD immunolocalization_NN ,_, using_VBG an_DT anti-peptide_JJ
          rabbit_NN antibody_NN ,_, on_IN various_JJ rat_NN liver_NN and_CC intestinal_NN
          sections_NNS (_( Fig_NNP ._. 9_CD )_) ._. We_PRP did_VBD not_RB observe_VB any_DT differences_NNS
          between_IN the_DT staining_VBG patterns_NNS observed_VBD for_IN the_DT control_NN
          rat_NN strains_NNS (_( Wistar_NNP or_CC SD_NNP )_) and_CC the_DT mutant_JJ hypertensive_JJ
          strains_NNS (_( SHR_NNP ,_, SHRSP_NNP )_) ._. Interestingly_RB ,_, we_PRP observed_VBD a_DT clear_JJ
          apical_JJ staining_VBG pattern_NN for_IN 
          Abcg_NNP 5_CD in_IN the_DT intestine_NN and_CC this_DT was_VBD
          not_RB altered_VBN in_IN the_DT mutant_JJ strains_NNS (_( Fig_NNP ._. 9_CD ,_, panel_NN B_NNP )_) ._.
        
      
      
        Discussion_NNP
        Recent_JJ studies_NNS on_IN ABC_NNP transporters_NNS have_VBP significantly_RB
        advanced_VBN our_PRP$ understanding_NN of_IN intestinal_NN sterol_NN absorption_NN
        and_CC biliary_JJ excretion_NN [_NN 33_CD ]_NN ._. Sterols_NNP are_VBP essential_JJ
        constituents_NNS of_IN cellular_JJ membranes_NNS in_IN human_JJ ,_, animals_NNS and_CC
        plants_NNS ._. In_IN humans_NNS and_CC animals_NNS ,_, cholesterol_NN is_VBZ the_DT sterol_NN
        that_WDT is_VBZ synthesised_JJ ,_, absorbed_VBN and_CC utilised_JJ ,_, whereas_IN plants_NNS
        do_VBP not_RB synthesise_NN cholesterol_NN ,_, but_CC use_NN molecules_NNS that_WDT are_VBP
        similar_JJ ,_, such_JJ as_IN sitosterol_NN ,_, campesterol_NN and_CC stigmasterol_NN ._.
        Although_IN similar_JJ amounts_NNS of_IN cholesterol_NN and_CC plant_NN sterols_NNS
        are_VBP present_JJ in_IN the_DT typical_JJ human_JJ diet_NN ,_, the_DT intestine_NN of_IN
        normal_JJ subjects_NNS provides_VBZ an_DT efficient_JJ barrier_NN against_IN the_DT
        absorption_NN of_IN the_DT majority_NN of_IN plant_NN sterols_NNS [_NN 3_CD ]_NN ._. On_IN
        average_JJ ,_, <_NN 1_CD -_: 5_CD %_NN of_IN dietary_JJ plant_NN sterols_NNS are_VBP absorbed_VBN
        and_CC retained_VBN compared_VBN with_IN ~_NN 55_CD %_NN of_IN dietary_JJ cholesterol_NN [_NN 3_CD
        34_CD ]_NN ._. Thus_RB ,_, in_IN healthy_JJ individuals_NNS ,_, there_EX exists_VBZ an_DT
        exquisite_JJ mechanism_NN that_WDT allows_VBZ the_DT body_NN to_TO distinguish_VB
        between_IN cholesterol_NN and_CC non-cholesterol_JJ sterols_NNS ._. ABCG_NNP 5_CD and_CC
        ABCG_NNP 8_CD are_VBP two_CD genes_NNS located_VBN adjacently_RB in_IN a_DT head-to-head_RB
        configuration_NN on_IN human_JJ chromosome_NN 2_CD p_NN 21_CD ,_, encoding_VBG for_IN two_CD
        half-transporters_JJ ,_, sterolin_NN 1_CD and_CC sterolin_NN 2_CD respectively_RB [_NN
        9_CD 10_CD 12_CD ]_NN ._. Mutations_NNP in_IN either_DT of_IN these_DT genes_NNS causes_NNS
        sitosterolemia_NN ,_, characterized_VBN by_IN hyperabsorption_NN of_IN
        phytosterols_NNS ,_, reduced_VBN excretion_NN of_IN sterols_NNS into_IN the_DT bile_NN
        and_CC very_RB elevated_VBD levels_NNS of_IN plasma_NN plant_NN sterol_NN levels_NNS ._. In_IN
        sitosterolemic_JJ patients_NNS ,_, the_DT absorption_NN of_IN phytosterols_NNS in_IN
        intestine_NN is_VBZ dramatically_RB increased_VBN ,_, with_IN absorption_NN of_IN
        plant_NN sterols_NNS to_TO about_IN the_DT same_JJ extent_NN (_( ~_NN 60_CD %_NN )_) as_IN
        cholesterol_NN ._.
        Interestingly_RB ,_, a_DT similar_JJ whole-body_JJ accumulation_NN of_IN
        plant_NN sterols_NNS ,_, less_RBR severe_JJ than_IN in_IN human_JJ sitosterolemia_NN ,_,
        has_VBZ been_VBN reported_VBN recently_RB in_IN SHR_NNP ,_, SHRSP_NNP and_CC WKY_NNP rats_NNS ,_, but_CC
        not_RB in_IN the_DT other_JJ genetically_RB related_VBN rat_NN strains_NNS ,_, such_JJ as_IN
        SD_NNP ,_, Wistar_NNP and_CC WKA_NNP rats_NNS [_NN 16_CD ]_NN ._. These_DT rats_NNS exhibit_NN defects_NNS
        at_IN two_CD levels_NNS :_: increased_VBN absorption_NN of_IN sterols_NNS (_( plant_NN and_CC
        animal_NN )_) at_IN the_DT intestinal_NN level_NN and_CC decreased_VBD excretion_NN of_IN
        sterols_NNS into_IN bile_NN [_NN 16_CD ]_NN ._. The_DT higher_JJR sterol_NN absorption_NN in_IN
        the_DT intestine_NN and_CC the_DT lower_JJR biliary_JJ excretion_NN of_IN plant_NN
        sterols_NNS in_IN these_DT rat_NN strains_NNS led_VBD us_PRP to_TO hypothesise_NN that_IN 
        Abcg_NNP 5_CD or_CC 
        Abcg_NNP 8_CD gene_NN mutations_NNS may_MD be_VB
        responsible_JJ for_IN the_DT sitosterolemia_NN observed_VBD in_IN these_DT
        hypertensive_JJ rats_NNS ._.
        Characterization_NNP of_IN the_DT rat_NN 
        STSL_NNP locus_JJ showed_VBD that_IN it_PRP is_VBZ highly_RB
        conserved_JJ in_IN organization_NN ,_, and_CC maps_NNS to_TO rat_VB chromosome_NN 6_CD q_NN 12_CD ,_,
        a_DT region_NN also_RB syntenic_JJ with_IN the_DT mouse_NN and_CC human_JJ 
        STSL_NNP loci_NN ._. Rat_NNP 
        Abcg_NNP 5_CD and_CC 
        Abcg_NNP 8_CD are_VBP expressed_VBN in_IN a_DT
        tissue-specific_JJ manner_NN ,_, with_IN expression_NN confined_VBN to_TO the_DT
        liver_NN and_CC the_DT intestine_NN ._. We_PRP sequenced_JJ the_DT 
        STSL_NNP loci_NN in_IN sitosterolemic_JJ and_CC
        control_NN rat_NN strains_NNS and_CC identified_VBD a_DT number_NN of_IN nucleotide_NN
        changes_NNS ._. Most_JJS of_IN these_DT nucleotide_NN changes_NNS were_VBD in_IN intronic_JJ
        regions_NNS and_CC ,_, based_VBN upon_IN their_PRP$ locations_NNS ,_, are_VBP likely_JJ to_TO be_VB
        '_POS silent_JJ '_'' ._. However_RB ,_, one_CD change_NN ,_, G_NNP 1754_CD T_NN in_IN exon_NN 12_CD was_VBD
        identified_VBN that_WDT led_VBD to_TO a_DT coding_VBG change_NN of_IN Gly_NNP 583_CD Cys_NNP in_IN
        sterolin-_NN 1_CD (_( 
        Abcg_NNP 5_LS )_) ._. This_DT change_NN was_VBD found_VBN only_RB
        in_IN rat_NN strains_NNS that_WDT were_VBD confirmed_VBN to_TO be_VB sitosterolemic_JJ
        (_( WKY_NNP ,_, SHR_NNP and_CC SHRSP_NNP )_) ,_, but_CC not_RB in_IN any_DT of_IN the_DT other_JJ strains_NNS
        screened_VBD (_( SD_NNP ,_, Wistar_NNP ,_, WKA_NNP ,_, GH_NNP or_CC BN_NNP )_) ._.
        The_DT significance_NN of_IN other_JJ genetic_JJ variances_NNS in_IN 
        Abcg_NNP 5_CD and_CC 
        Abcg_NNP 8_CD in_IN different_JJ rat_NN strains_NNS
        documented_VBN in_IN this_DT study_NN is_VBZ presently_RB unknown_JJ ._. Plant_NN sterol_NN
        metabolism_NN has_VBZ been_VBN extensively_RB evaluated_VBN in_IN different_JJ rat_NN
        strains_NNS ,_, but_CC the_DT accumulation_NN of_IN plant_NN sterols_NNS occurs_VBZ only_RB
        in_IN SHR_NNP ,_, SHRSP_NNP and_CC WKY_NNP rats_NNS ._. The_DT predicted_VBD 6_CD trans-membrane_JJ
        domain_NN model_NN of_IN sterolin-_NN 1_CD indicates_VBZ that_IN the_DT Gly_NNP 583_CD Cys_NNP
        missense_NN mutation_NN is_VBZ located_VBN within_IN the_DT third_JJ extracellular_NN
        loop_NN (_( residues_NNS 554_CD -_: 620_CD )_) ,_, in_IN a_DT conserved_JJ region_NN (_( Fig_NNP 5_CD C_NNP )_) and_CC
        is_VBZ adjacent_JJ to_TO two_CD potential_JJ 
        N_NNP -_: glycosylation_NN sites_NNS (_( residues_NNS 585_CD
        and_CC 594_CD )_) ._. Thus_RB a_DT mutation_NN at_IN residue_NN 583_CD could_MD disrupt_VB the_DT
        first_JJ site_NN ._. Finally_RB ,_, both_DT the_DT sterolin-_NN 1_CD and_CC sterolin-_NN 2_CD are_VBP
        cysteine-rich_JJ proteins_NNS (_( 16_CD cysteines_NNS in_IN sterolin_NN 1_CD and_CC 14_CD
        in_IN sterolin_NN 2_LS )_) ,_, five_CD of_IN these_DT cyteines_NNS in_IN sterolin-_NN 1_CD are_VBP
        present_JJ in_IN the_DT extracellular_NN loop_NN containing_VBG the_DT mutation_NN ._.
        It_PRP is_VBZ tempting_JJ to_TO speculate_VB that_IN the_DT gain_NN of_IN an_DT additional_JJ
        cysteine_NN in_IN sterolin-_NN 1_CD by_IN the_DT Gly_NNP 583_CD Cys_NNP missense_NN mutation_NN
        might_MD affect_VB intracellular_NN trafficking_NN or_CC the_DT
        heterodimerization_NN with_IN sterolin-_NN 2_CD ._. This_DT possibility_NN is_VBZ
        diminished_VBN but_CC not_RB eliminated_VBN by_IN the_DT demonstration_NN that_IN in_IN
        both_DT the_DT mutant_JJ and_CC control_NN rats_NNS ,_, 
        Abcg_NNP 5_CD is_VBZ located_VBN apically_RB in_IN the_DT
        intestine_NN (_( Fig_NNP ._. 9_CD )_) ._. Evidence_NN that_DT sterolin-_NN 1_CD and_CC sterolin-_NN 2_CD
        may_MD heterodimerize_NN has_VBZ now_RB been_VBN presented_VBN ,_, based_VBN upon_IN in_IN
        vitro_NN analyses_NNS [_NN 13_CD ]_NN ._. However_RB ,_, our_PRP$ preliminary_JJ analyses_NNS
        of_IN immunohistochemistry_NN ,_, using_VBG an_DT antibody_NN to_TO sterolin-_NN 1_CD
        suggests_VBZ that_IN the_DT pattern_NN of_IN expression_NN in_IN the_DT liver_NN and_CC
        intestine_NN is_VBZ similar_JJ for_IN both_DT SD_NNP as_RB well_RB as_IN WKY_NNP or_CC SHR_NNP rats_NNS
        (_( Fig_NNP ._. 9_CD )_) ._. These_DT studies_NNS are_VBP limited_JJ in_IN scope_NN ,_, as_IN antibody_NN
        reagents_NNS to_TO detect_VB rat_NN sterolin-_NN 2_CD are_VBP not_RB currently_RB
        available_JJ ._.
        Another_DT formal_JJ possibility_NN not_RB excluded_VBD is_VBZ that_IN the_DT
        Gly_NNP 583_CD Cys_NNP missense_NN mutation_NN may_MD have_VB no_DT significance_NN in_IN the_DT
        accumulation_NN of_IN phytosterols_NNS in_IN WKY_NNP ,_, SHR_NNP and_CC SHRSP_NNP ,_, and_CC
        that_IN the_DT alteration_NN in_IN the_DT 3_CD '_POS UTR_NNP or_CC even_RB the_DT intronic_JJ
        changes_NNS reported_VBD above_IN may_MD be_VB the_DT causative_JJ '_POS mutations_NNS '_'' ._.
        Our_PRP$ analyses_NNS of_IN the_DT mRNA_NN and_CC protein_NN profiles_NNS would_MD not_RB
        strongly_RB support_VB these_DT possibilities_NNS ._. However_RB ,_, further_JJ
        investigation_NN will_MD be_VB required_VBN to_TO determine_VB if_IN the_DT 3_CD -_: base_NN
        insertion_NN in_IN the_DT predicted_VBN 3_CD '_POS UTR_NNP of_IN 
        Abcg_NNP 8_CD has_VBZ any_DT functional_JJ consequence_NN ._.
        In_IN the_DT absence_NN of_IN a_DT direct_JJ assay_NN for_IN sterolin-_NN 1_CD and_CC -_: 2_CD
        function_NN ,_, the_DT genetic_JJ changes_NNS presented_VBN ,_, together_RB with_IN the_DT
        correlation_NN of_IN the_DT phenotypes_NNS ,_, remains_VBZ the_DT strongest_JJS
        evidence_NN that_IN these_DT genetic_JJ alterations_NNS are_VBP functional_JJ ,_, and_CC
        that_IN the_DT Gly_NNP 583_CD Cys_NNP is_VBZ a_DT mutational_NN change_NN ._.
        A_DT more_RBR relevant_JJ question_NN raised_VBD in_IN this_DT study_NN is_VBZ whether_IN
        the_DT plant_NN sterol_NN accumulation_NN in_IN hypertensive_JJ rat_NN strains_NNS
        has_VBZ significance_NN in_IN the_DT pathophysiology_NN of_IN hypertension_NN ._.
        Recent_JJ linkage_NN mapping_NN studies_NNS mapped_VBN hypertension_NN QTLs_NNP to_TO
        a_DT number_NN of_IN chromosomal_NN regions_NNS in_IN SHR_NNP and_CC SHRSP_NNP rats_NNS [_NN 35_CD
        ]_NN ._. Our_PRP$ FISH_NNP study_NN assigned_VBN the_DT 
        STSL_NNP locus_JJ rat_NN chromosome_NN 6_CD q_NN 12_CD ,_, a_DT
        region_NN where_WRB a_DT cluster_NN of_IN blood_NN pressure_NN QTL_NNP with_IN Lod_NNP score_NN
        4_CD ~_NN 6_CD has_VBZ been_VBN reported_VBN to_TO be_VB present_JJ (_( M_NNP 6_CD MIT_NNP 12_CD -_: M_NNP 6_CD MIT_NNP 3_CD ,_, 39_CD cM_NN
        distance_NN )_) in_IN a_DT New_NNP Zealand_NNP genetically_RB hypertensive_JJ rat_NN (_( GH_NNP
        rat_NN )_) [_NN 35_CD ]_NN ._. With_IN respect_NN to_TO hypertension_NN ,_, although_IN the_DT
        SHR_NNP and_CC SHRSP_NNP strains_NNS carry_VBP the_DT Gly_NNP 583_CD Cys_NNP mutation_NN ,_, in_IN
        extensive_JJ QTL_NNP mapping_NN studies_NNS using_VBG these_DT strains_NNS ,_, no_DT loci_NN
        mapping_NN to_TO the_DT rat_NN 
        STSL_NNP region_NN have_VBP been_VBN reported_VBN [_NN 35_CD ]_NN
        ._. In_IN our_PRP$ study_NN ,_, the_DT GH_NNP rat_NN is_VBZ neither_DT sitosterolemic_JJ ,_, nor_CC
        has_VBZ any_DT nucleotide_NN alteration_NN at_IN the_DT 
        STSL_NNP locus_JJ that_WDT would_MD implicate_VB this_DT
        region_NN as_IN mutated_VBN ._. Thus_RB we_PRP do_VBP not_RB believe_VB the_DT 
        STSL_NNP locus_JJ plays_VBZ a_DT role_NN in_IN
        determining_VBG blood_NN pressure_NN ._. However_RB ,_, it_PRP may_MD play_VB a_DT
        significant_JJ role_NN in_IN modifying_VBG the_DT pathophysiology_NN ._.
        Studies_NNS reported_VBN by_IN different_JJ investigators_NNS have_VBP shown_VBN
        that_IN a_DT dietary_JJ intake_NN of_IN 10_CD %_NN canola_NN oil_NN (_( as_IN part_NN of_IN
        semi-purified_JJ diets_NNS )_) significantly_RB shortened_VBN the_DT life-span_JJ
        of_IN SHRSP_NNP rats_NNS ,_, with_IN accumulation_NN of_IN phytosterols_NNS in_IN plasma_NN ,_,
        red_JJ blood_NN cells_NNS and_CC tissues_NNS [_NN 15_CD 17_CD 18_CD 19_CD 21_CD 22_CD ]_NN ._. Lower_JJR
        red_JJ blood_NN cell_NN (_( RBC_NNP )_) membrane_NN deformability_NN ,_, lower_JJR density_NN
        of_IN platelets_NNS ,_, as_RB well_RB as_IN a_DT higher_JJR blood_NN pressure_NN were_VBD also_RB
        observed_VBN ,_, when_WRB compared_VBN to_TO a_DT SHRSP_NNP group_NN fed_VBN with_IN vegetable_NN
        oils_NNS lower_JJR in_IN phytosterols_NNS (_( 10_CD %_NN soybean_NN oil_NN 
        vs_NNS ._. 10_CD %_NN canola_NN oil_NN )_) ._. Canola_NNP oil_NN has_VBZ a_DT
        higher_JJR sitosterol_NN content_NN than_IN soybean_NN oil_NN ._. In_IN comparison_NN ,_,
        extensive_JJ studies_NNS on_IN evaluation_NN of_IN high_JJ phytosterol_NN diets_NNS
        in_IN SD_NNP rats_NNS (_( non-sitosterolemic_JJ )_) have_VBP consistently_RB shown_VBN to_TO
        be_VB safe_JJ without_IN any_DT adverse_JJ consequences_NNS [_NN 36_CD 37_CD 38_CD 39_CD 40_CD
        41_CD 42_CD ]_NN ._. These_DT intriguing_JJ differences_NNS between_IN SHRSP_NNP and_CC SD_NNP
        rats_NNS may_MD now_RB be_VB explained_VBN ,_, at_IN least_JJS in_IN part_NN ,_, by_IN presence_NN of_IN
        the_DT Gly_NNP 583_CD Cys_NNP missense_NN mutation_NN in_IN sterolin-_NN 1_CD ._. The_DT WKY_NNP rat_NN
        also_RB carries_VBZ this_DT mutation_NN and_CC a_DT high_JJ dietary_JJ intake_NN of_IN
        phytosterols_NNS will_MD also_RB increase_VB the_DT blood_NN pressure_NN and_CC
        decrease_VB the_DT density_NN of_IN platelets_NNS ,_, though_IN to_TO a_DT lower_JJR extent_NN
        than_IN that_DT observed_VBD in_IN SHRSP_NNP rats_NNS [_NN 20_CD ]_NN ._. These_DT data_NNS
        support_VBP a_DT pathological_JJ role_NN of_IN elevated_JJ plant_NN sterols_NNS in_IN
        these_DT rats_NNS and_CC support_VB the_DT notion_NN that_IN the_DT 
        STSL_NNP loci_NN evolved_VBD to_TO not_RB only_RB allow_VB
        for_IN the_DT excretion_NN of_IN cholesterol_NN into_IN bile_NN ,_, but_CC also_RB to_TO
        keep_VB '_POS xeno-sterols_JJ '_POS from_IN accumulating_VBG in_IN the_DT body_NN ._. With_IN
        respect_NN to_TO sitosterolemia_NN in_IN humans_NNS ,_, although_IN
        atherosclerotic_JJ complications_NNS have_VBP been_VBN well-described_JJ ,_,
        hypertension_NN has_VBZ not_RB been_VBN mentioned_VBN as_IN feature_NN ._. However_RB ,_, it_PRP
        is_VBZ not_RB known_VBN whether_IN the_DT atherosclerosis_NNS in_IN sitosterolemic_JJ
        patients_NNS with_IN hypertension_NN is_VBZ accelerated_VBN ,_, relative_JJ to_TO
        those_DT affected_VBN individuals_NNS with_IN lower_JJR blood_NN pressures_NNS ._.
        The_DT Gly_NNP 583_CD Cys_NNP mutation_NN in_IN 
        Abcg_NNP 5_CD is_VBZ likely_JJ to_TO have_VB originated_VBN in_IN
        the_DT original_JJ outbred_JJ Wistar_NNP colony_NN bred_VBN in_IN Kyoto_NNP (_( from_IN
        which_WDT WKY_NNP was_VBD subsequently_RB derived_VBN )_) ,_, which_WDT has_VBZ been_VBN widely_RB
        employed_VBN as_IN a_DT normotensive_JJ control_NN in_IN experimental_JJ studies_NNS
        of_IN hypertension_NN ._. It_PRP gave_VBD rise_NN to_TO the_DT SHR_NNP and_CC SHRSP_NNP strains_NNS ._.
        Thus_RB ,_, this_DT mutation_NN in_IN WKY_NNP ,_, SHR_NNP and_CC SHRSP_NNP lines_NNS may_MD not_RB
        contribute_VB to_TO the_DT hypertension_NN phenotype_NN 
        per_IN se_FW ,_, but_CC may_MD only_RB be_VB responsible_JJ
        for_IN sitosterolemia_NN ._. The_DT original_JJ Wistar_NNP colony_NN was_VBD
        established_VBN at_IN the_DT Wistar_NNP Institute_NNP in_IN 1906_CD ,_, and_CC the_DT
        Sprague_NNP Dawley_NNP colony_NN was_VBD derived_VBN by_IN Dawley_NNP in_IN
        approximately_RB 1925_CD from_IN a_DT single_JJ male_NN of_IN unknown_JJ origin_NN and_CC
        a_DT Wistar_NNP female_NN ._. The_DT SHR_NNP strain_NN was_VBD derived_VBN by_IN selective_JJ
        inbreeding_VBG from_IN the_DT Kyoto_NNP outbred_JJ Wistar_NNP colony_NN ,_, and_CC both_DT
        SHR_NNP and_CC SHRSP_NNP ,_, as_RB well_RB as_IN WKY_NNP strains_NNS have_VBP been_VBN maintained_VBN
        over_IN many_JJ generations_NNS through_IN brother-sister_JJ matings_NNS
        http_NN :_: /_NN /_NN rgd_NN ._. mcw_NN ._. edu_NN /_NN tools_NNS /_NN strains_NNS [_NN 43_CD 44_CD ]_NN ._. Healthy_JJ WKA_NNP
        and_CC GH_NNP rat_NN strains_NNS were_VBD also_RB generated_VBN from_IN outbred_JJ Wistar_NNP
        rat_NN strains_NNS ,_, but_CC these_DT strains_NNS were_VBD isolated_VBN independently_RB
        in_IN Japan_NNP and_CC New_NNP Zealand_NNP ,_, respectively_RB (_( and_CC maintained_VBN at_IN
        other_JJ sites_NNS as_RB well_RB )_) ._. The_DT GH_NNP rat_NN was_VBD selected_VBN for_IN systolic_JJ
        hypertension_NN that_WDT increased_VBD with_IN successive_JJ generations_NNS and_CC
        maintained_VBN through_IN filial_JJ matings_NNS [_NN 45_CD ]_NN ._. In_IN view_NN of_IN this_DT ,_,
        the_DT Gly_NNP 583_CD Cys_NNP missense_NN mutation_NN of_IN 
        Abcg_NNP 5_CD might_MD result_VB from_IN occurrence_NN of_IN
        a_DT 
        de_IN novo_NN mutation_NN during_IN breeding_VBG at_IN
        the_DT stage_NN of_IN developing_VBG inbred_JJ WKY_NNP strains_NNS and_CC propagated_JJ
        into_IN the_DT SHR_NNP and_CC SHRSP_NNP lines_NNS ._. In_IN contrast_NN ,_, the_DT 143_CD
        nucleotide_NN fragment_NN insertion_NN polymorphism_NN in_IN the_DT 3_CD '_POS -_: UTR_NNP of_IN
        
        Abcg_NNP 8_CD may_MD have_VB resulted_VBN from_IN
        acquisition_NN of_IN a_DT foreign_JJ chromosomal_NN fragment_NN during_IN the_DT
        Wistar_NNP rat_NN strain_NN breeding_NN and_CC established_VBN as_IN homozygous_JJ
        change_NN in_IN the_DT WKY_NNP ,_, SHR_NNP and_CC SHRSP_NNP ,_, as_RB well_RB as_IN GH_NNP rat_NN
        strains_NNS ._. In_IN this_DT context_NN ,_, it_PRP is_VBZ important_JJ to_TO note_VB that_IN 3_CD
        other_JJ mutant_JJ loci_NN have_VBP been_VBN reported_VBN in_IN the_DT SHR_NNP rat_NN ;_:
        missense_NN mutations_NNS in_IN the_DT 
        KAT-_NNP 1_CD (_( kynurenine_NN
        aminotransferase-_NN 1_LS )_) ,_, 
        Srebf-_NNP 1_CD (_( sterol_NN regulatory_JJ element_NN
        binding_JJ factor-_NN 1_LS )_) and_CC 
        CD_NNP 36_CD (_( fatty_NN acid_NN translocase_NN )_) are_VBP all_DT
        present_NN as_IN homozygous_JJ changes_NNS [_NN 46_CD 47_CD 48_CD ]_NN ._. The_DT generation_NN
        of_IN congenic_JJ lines_NNS may_MD assist_VB with_IN addressing_VBG many_JJ of_IN these_DT
        issues_NNS ._. Such_JJ lines_NNS will_MD be_VB useful_JJ in_IN demonstrating_VBG that_IN the_DT
        variant_NN sterolin-_NN 1_CD protein_NN is_VBZ responsible_JJ for_IN causing_VBG
        sitosterolemia_NN ,_, but_CC will_MD allow_VB comparisons_NNS between_IN animals_NNS
        that_WDT are_VBP hypertensive_JJ and_CC those_DT that_WDT are_VBP hypertensive_JJ and_CC
        sitosterolemic_JJ ._. Currently_RB ,_, there_EX are_VBP no_DT appropriate_JJ genetic_JJ
        controls_NNS available_JJ ,_, as_IN SHR_NNP ,_, SHRSP_NNP and_CC WKY_NNP are_VBP all_DT
        maintained_VBN as_IN colonies_NNS by_IN brother-sister_JJ matings_NNS ._. While_IN
        this_DT manuscript_NN was_VBD in_IN review_NN ,_, Scoggan_NNP 
        et_CC al_NN also_RB reported_VBD identifying_VBG
        Gly_NNP 583_CD Cys_NNP alteration_NN in_IN 
        Abcg_NNP 5_CD of_IN SHR_NNP ,_, SHRP_NNP and_CC WKY_NNP rats_NNS [_NN 49_CD
        ]_NN ._.
      
      
        Conclusion_NNP
        Three_CD rat_NN strain_NN ,_, WKY_NNP ,_, SHR_NNP and_CC SHRSP_NNP ,_, that_WDT are_VBP
        hypertensive_JJ are_VBP also_RB sitosterolemic_JJ ._. All_DT of_IN these_DT strains_NNS
        are_VBP homozygous_JJ mutant_JJ for_IN Gly_NNP 583_CD Cys_NNP in_IN sterolin-_NN 1_CD ,_, encoded_JJ
        by_IN 
        Abcg_NNP 5_CD ._. This_DT mutation_NN is_VBZ not_RB present_JJ
        in_IN rats_NNS that_WDT were_VBD not_RB sitosterolemic_JJ ,_, even_RB though_IN one_CD of_IN
        these_DT was_VBD hypertensive_JJ (_( the_DT GH_NNP rat_NN )_) ._. The_DT rat_NN 
        STSL_NNP locus_JJ ,_, comprising_VBG of_IN 
        Abcg_NNP 5_CD and_CC 
        Abcg_NNP 8_CD ,_, maps_NNS to_TO rat_VB chromosome_NN 6_CD q_NN 12_CD ,_,
        a_DT region_NN syntenic_JJ with_IN both_DT mouse_NN and_CC human_JJ 
        STSL_NNP loci_NN ._. Preliminary_JJ antibody_NN
        studies_NNS show_VBP that_IN this_DT mutant_JJ protein_NN is_VBZ expressed_VBN and_CC
        appears_VBZ to_TO be_VB apically_RB targeted_VBN in_IN the_DT intestinal_NN
        cells_NNS ._.
      
      
        Competing_VBG Interests_NNP
        None_NN declared_VBD ._.
      
      
        Authors_NNP '_'' contributions_NNS
        HY_NNP conceived_VBD this_DT study_NN ,_, HY_NNP ,_, BP_NNP ,_, and_CC KL_NNP performed_VBD the_DT
        molecular_JJ genetic_JJ studies_NNS ,_, EK_NNP performed_VBD the_DT real_JJ time_NN PCR_NNP
        and_CC the_DT western_JJ blotting_VBG assays_NNS ,_, M-HL_NNP performed_VBD the_DT
        immunostaining_VBG ,_, KH_NNP performed_VBD the_DT FISH_NNP assay_NN ,_, RK_NNP and_CC AB_NNP
        performed_VBD the_DT sterol_NN analyses_NNS ,_, MS_NNP and_CC NE_NNP performed_VBD the_DT DNA_NNP
        isolations_NNS from_IN the_DT rats_NNS ._. HY_NNP ,_, GS_NNP ,_, IK_NNP ,_, TR_NNP and_CC SBP_NNP were_VBD
        responsible_JJ for_IN supervision_NN ,_, and_CC data_NNS analyses_NNS of_IN the_DT
        experiments_NNS ,_, as_RB well_RB as_IN for_IN providing_VBG the_DT funding_NN ._. HY_NNP and_CC
        SBP_NNP wrote_VBD the_DT paper_NN ._. All_DT authors_NNS read_VBP and_CC approved_VBD the_DT
        final_JJ manuscript_NN ._.
      
    
  
